2017
DOI: 10.1111/trf.14396
|View full text |Cite
|
Sign up to set email alerts
|

In premature infants there is no decrease in 24‐hour posttransfusion allogeneic red blood cell recovery after 42 days of storage

Abstract: Background Critically ill preterm very low birth weight (VLBW) neonates (birthweight ≤1.5 kg) frequently develop anemia that is treated with red blood cell (RBC) transfusions. Although RBC transfused to adults demonstrate progressive decreases in post-transfusion 24-hour RBC recovery (PTR24) during storage—to a mean of about 85% of the FDA allowed 42-day storage—limited data in infants indicate no decrease in PTR24 with storage. Study Design and Methods We hypothesized that PTR24 of allogeneic RBCs transfuse… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 8 publications
(9 citation statements)
references
References 27 publications
0
9
0
Order By: Relevance
“…In addition, PTR in healthy subjects does not suffice to provide information on the actual RBC recovery in nonhealthy, heterologous patients. Several studies have highlighted that PTR of allogenically transfused RBC in patients with acute inflammatory disorders is significantly reduced, while in patients with immature innate immune systems, the PTR is increased or is insensitive to age‐mediated storage …”
Section: Discussionmentioning
confidence: 99%
“…In addition, PTR in healthy subjects does not suffice to provide information on the actual RBC recovery in nonhealthy, heterologous patients. Several studies have highlighted that PTR of allogenically transfused RBC in patients with acute inflammatory disorders is significantly reduced, while in patients with immature innate immune systems, the PTR is increased or is insensitive to age‐mediated storage …”
Section: Discussionmentioning
confidence: 99%
“…Multiple determinations of PTR 24 can be made based on the ratio of BioRBC‐N enrichment at 24 hours relative to that immediately following the BioRBC transfusion. In all studies using fresh autologous or stored donor RBCs in naïve subjects, PTR 24 values for the BioRBC‐N have consistently agreed within analytical error, providing evidence that there is negligible early cell loss of BioRBC‐N . The FDA relies exclusively on 51 Cr‐labeled RBCs for determination of PTR 24 for regulatory review of safety and efficacy (e.g., licensing of RBC storage media) .…”
Section: Comparison Of Biotin‐ and 51cr‐labeled Rbcs For Kinetic Studiesmentioning
confidence: 91%
“…Additional studies may be needed to directly assess smoking exposure through the measurement of cotinine levels in donated RBC units as well as the impact of smoking and other donor factors on RBC recovery and survival studies. 43,44 [Color figure can be viewed at wileyonlinelibrary.com] However, our findings are reassuring that donor tobacco use does not appear to have an effect on recipient outcomes.…”
Section: Discussionmentioning
confidence: 56%
“…However, we saw no association between donor hemoglobin levels, obesity, or self‐reported smoking status and hospital mortality or length of stay. Additional studies may be needed to directly assess smoking exposure through the measurement of cotinine levels in donated RBC units as well as the impact of smoking and other donor factors on RBC recovery and survival studies . However, our findings are reassuring that donor tobacco use does not appear to have an effect on recipient outcomes.…”
Section: Discussionmentioning
confidence: 65%
See 1 more Smart Citation